Masahiko Oguchi Selected Research

Masahiko Oguchi Research Topics

Disease

23	Neoplasms (Cancer) 01/2021 - 08/2003
17	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2005
13	Lymphoma (Lymphomas) 01/2021 - 07/2007
8	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 03/2013
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2020 - 12/2009
6	Rectal Neoplasms (Rectal Cancer) 01/2020 - 09/2003
5	Margins of Excision 07/2022 - 03/2015
5	Carcinoma (Carcinomatosis) 01/2019 - 11/2006
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 11/2009
3	Neoplasm Metastasis (Metastasis) 11/2020 - 05/2012
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019 - 07/2016
3	Esophageal Neoplasms (Esophageal Cancer) 10/2009 - 07/2003
2	Body Weight (Weight, Body) 01/2020 - 10/2012
2	Neutropenia 01/2020 - 01/2015
2	Adenocarcinoma 08/2019 - 01/2015
2	Disease Progression 06/2018 - 08/2003
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 09/2012
2	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2017 - 01/2006
2	Squamous Cell Carcinoma of Head and Neck 05/2013 - 09/2003
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 11/2007 - 08/2003
1	Extranodal NK-T-Cell Lymphoma 10/2022
1	Lymphatic Metastasis 07/2022
1	Unilateral Breast Neoplasms 03/2022
1	Cardiotoxicity 03/2022
1	Pain (Aches) 11/2020
1	Spinal Fractures 11/2020
1	Diarrhea 01/2020
1	Rib Fractures (Rib Fracture) 05/2018
1	Jaundice (Icterus) 11/2016
1	Lung Neoplasms (Lung Cancer) 04/2015
1	Cicatrix (Scar) 03/2015
1	Scirrhous Adenocarcinoma (Scirrhous Carcinoma) 01/2015
1	Hemorrhage 07/2014
1	Hematuria 07/2014
1	Cystitis 07/2014
1	Telangiectasis (Telangiectasia) 07/2014
1	Stress Fractures (Stress Fracture) 10/2012
1	Dermatitis 05/2008
1	Pneumonia (Pneumonitis) 05/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2006
1	Second Primary Neoplasms (Neoplasms, Second) 09/2006
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 09/2004
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2003
1	Residual Neoplasm 07/2003
1	Nasopharyngeal Carcinoma 01/2003

Drug/Important Bio-Agent (IBA)

4	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2019 - 01/2015
3	AnthracyclinesIBA 10/2022 - 06/2018
2	Cisplatin (Platino)FDA LinkGeneric 10/2012 - 10/2010
1	Asparaginase (Elspar)FDA Link 11/2020
1	Prealbumin (Transthyretin)IBA 01/2020
1	Serum AlbuminIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 08/2019
1	Bevacizumab (Avastin)FDA Link 08/2019
1	Leucovorin (Folinic Acid)FDA Link 08/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	Estrogen ReceptorsIBA 07/2018
1	Histones (Histone)IBA 02/2018
1	Dihydrotachysterol (AT 10)IBA 07/2017
1	Hormones (Hormone)IBA 11/2016
1	AndrogensIBA 02/2015
1	4-azidobenzylcarazolol (pABC)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 11/2014
1	Saline SolutionIBA 07/2014
1	Hemoglobins (Hemoglobin)IBA 07/2014
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Cetuximab (Erbitux)FDA Link 05/2013
1	Iodine-125IBA 03/2013
1	Docetaxel (Taxotere)FDA Link 10/2010
1	Etoposide (VP 16)FDA LinkGeneric 11/2009
1	Vincristine (Oncovin)FDA LinkGeneric 09/2006
1	Prednisolone (Predate)FDA LinkGeneric 09/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2006

Therapy/Procedure

53	Radiotherapy 03/2022 - 01/2003
15	Chemoradiotherapy 01/2020 - 07/2007
12	Brachytherapy 07/2022 - 02/2008
10	Segmental Mastectomy (Lumpectomy) 07/2022 - 01/2005
7	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2022 - 06/2014
7	Drug Therapy (Chemotherapy) 11/2020 - 07/2003
6	Therapeutics 10/2022 - 01/2005
2	Neoadjuvant Therapy 08/2019 - 07/2018
2	Mastectomy (Mammectomy) 07/2018 - 07/2012
2	Prostatectomy (Retropubic Prostatectomy) 02/2015 - 12/2014
1	Conformal Radiotherapy 03/2022
1	Re-Irradiation 11/2020
1	Proctectomy 08/2019
1	Salvage Therapy 01/2019
1	Radical Mastectomy 07/2018
1	Drug Tapering 05/2018
1	Argon Plasma Coagulation 07/2014
1	Gastrointestinal Endoscopes 07/2014
1	Radiation Dosimeters 02/2008
1	Chemoprevention 01/2005
1	Duration of Therapy 01/2003